MMS · Maximus, Inc.
Price & Indicators
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
AI Brief
Q3 FY26 earnings call · Aug 6, 2026TL;DR. Maximus reported in-line Q3 revenue and margin gains but lowered FY2026 earnings, EBITDA margin, and free cash flow guidance due to a temporary customer-directed contractual modification on a major federal program (VA), while reiterating revenue guidance toward the low end.
- + Adjusted EBITDA margin expanded to 15.0% from 14.7% a year ago on AI/automation-driven efficiency gains.
- + Signed contract awards and awarded-but-unsigned contracts both expanded, with unsigned awards up materially on longer-duration recompete wins.
- + Defence and national security pipeline identified at nearly $47 billion, with notable wins at the Air Force and TSA.
- + SNAP opportunity ramping with 40+ Accuracy Assistant demonstrations and FY25 national payment error rate of ~10.6% reinforcing demand for accuracy tools.
- + AI initiatives are driving internal margin gains, with one 5-contract group achieving a 3.5% operating margin improvement.
- − FY2026 adjusted EPS guidance cut to $7.90–$8.20 and adjusted EBITDA margin to ~13.7% due to a temporary VA contractual modification.
- − FY2026 free cash flow guidance lowered to $425–$475 million from prior expectations.
- − VA incentive pause of ~180 days through December 31, 2026 reduces profitability; CFO signals Q4 13% implied EBITDA margin as a likely near-term run rate without those incentives.
- − Federal civilian market seeing procurement delays, scope revisions and cancellations; book-to-bill at only ~0.5x on a trailing-12-month basis.
- − Revenue declined 5.2% YoY to $1.28B and nine-month revenue fell ~4.4% to $3.93B, with FY26 revenue now expected toward the low end of the $5.2–$5.35B range.
- − Q3 free cash flow was an outflow of $137 million and DSO remained elevated at 98 days, despite post-quarter collections of $245M.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture- non-GAAP | $6.14 | For the Nine Months Ended June 30, 2026 | — |
| Adjusted EBITDA (Non-GAAP) non-GAAP | 550.77M | For the Nine Months Ended June 30, 2026 | — |
| Adjusted EBITDA margin (Non-GAAP) non-GAAP | 14% | For the Nine Months Ended June 30, 2026 | — |
| Adjusted net income excluding amortization of intangible assets and divestiture-related adjustme non-GAAP | 332.92M | For the Nine Months Ended June 30, 2026 | — |
| Consolidated EBITDA (as defined by our Credit Agreement) non-GAAP | $210.4M | the three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net income 103.59M
+23.88M Interest expense
-608K Other (income)/expense, net
+34.57M Provision for income taxes
+20.19M Amortization of intangibles
+7.36M Stock compensation expense
+0K Capitalized software impairment charges
-1.16M Divestiture-related (gains)/charges, net
+11.87M Depreciation and amortization of property, equipment, and capitalized software
+10.72M Pro forma and other adjustments permitted by our Credit Agreement
= Consolidated EBITDA (as defined by our Credit Agreement) 210.4M
|
|||
| Contracts pending (awarded but unsigned) | $1.35B | the third quarter of fiscal year 2026 | — |
| DSO | 98 | the third quarter of fiscal year 2026 | — |
| Free cash flow (Non-GAAP) non-GAAP | -208.62M | For the Nine Months Ended June 30, 2026 | — |
| Signed contract awards (year-to-date) | $1.25B | the third quarter of fiscal year 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Business Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MMS
this stock
Maximus, Inc.
|
$2.75B | -39.0% | -2.4% | 7.8 | 6.3% |
|
CTAS
Cintas Corp
|
$78.56B | +2.6% | +6.4% | 40.0 | 2.8% |
|
RELX
Relx PLC
|
$58.28B | -17.3% | — | — | 0.4% |
|
TRI
Thomson Reuters Corp /Can/
|
$42.89B | -26.0% | — | — | 2.9% |
|
CPRT
Copart Inc
|
$25.27B | -30.5% | +24.7% | 17.6 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MMS | +0.1% | -9.9% | -21.8% | -1.0% | -39.0% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | +0.3% | -9.4% | -34.0% | -1.9% | -51.9% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.